• Page

Global Medical Information Form

• Page

INTERNAL: Web Request Form for Commercial Sites Form

• Page

Reporting a Product Complaint

• Page

Report an Adverse Event

• Publication

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

Margareth C. Ozelo, M.D., Ph.D., Johnny Mahlangu, M.B., B.Ch., M.Med., K. John Pasi, M.D., Ph.D., Adam Giermasz, M.D., Ph.D., Andrew D. Leavitt, M.D., Michael Laffan, M.D., Ph.D., Emily Symington, M.D., Doris V. Quon, M.D., Ph.D., Jiaan-Der Wang, M.D., Ph.D., Kathelijne Peerlinck, M.D., Ph.D., Steven W. Pipe, M.D., Bella Madan, M.D., Nigel S. Key, M.D., Glenn F. Pierce, M.D., Ph.D., Brian O’Mahony, F.A.C.S.L.M., Radoslaw Kaczmarek, Ph.D., Joshua Henshaw, Ph.D., Adebayo Lawal, M.D., Kala Jayaram, M.D., Mei Huang, M.S., Xinqun Yang, Ph.D., Wing Y. Wong, M.D., and Benjamin Kim, M.D. for the GENEr8-1 Trial Group^*

• Leadership Profile

Jeff Ajer

• Board Profile

Barbara Bodem

• Board Profile

Mark Enyedy

• Board Profile

Alexander Hardy